
zzso intensive chemotherapy currently used to treat pediatric solid tumors zzso severe zzso zzso zzso is a major risk factor for septic death which occurs in up to zzso of zzso or septic zzso zzso We treated 18 zzso pediatric cancer patients zzso zzso 10 zzso during 30 zzso and/or septic episodes with single daily doses of zzso zzso zzso zzso human zzso zzso factor zzso 5 zzso per zzso of body zzso The zzso was administered for a median period of zzso days zzso zzso Analysis of circulating zzso zzso cells was performed at day 1 zzso and day 5 of zzso treatment and included flow zzso zzso analysis as well as the zzso zzso zzso zzso zzso recovery and resolution of septic problems was observed in all zzso The counts of zzso zzso absolute zzso zzso and zzso zzso rose above zzso zzso and zzso within 4 days zzso zzso days zzso and 6 days zzso zzso zzso zzso recovery and improved recruitment of circulating zzso precursors was observed in children with zzso amounts zzso zzso of zzso zzso cells prior to zzso zzso We conclude that, to some extent, the efficacy of zzso treatment in zzso cancer patients is influenced by the zzso recovery status on the zzso cell zzso Although they respond more slowly to the treatment, patients without circulating zzso zzso cells may gain most from growth factor zzso zzso can be safely administered to zzso and/or septic zzso children treated for zzso 

